Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2007-12-04
2007-12-04
Canella, Karen A. (Department: 1643)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C435S006120, C435S007230, C436S501000, C436S063000, C436S064000
Reexamination Certificate
active
10961615
ABSTRACT:
The present invention provides a method for diagnosing breast cancer in a subject. The present invention also provides a method for treating breast cancer in a subject. Finally, the present invention provides a method for assessing the efficacy of breast cancer therapy in a subject who has undergone or is undergoing treatment for breast cancer.
REFERENCES:
Wapnir et al, J Clin Endocrinol Metab, Apr. 2003, vol. 88, pp. 1880-1888.
Vayre et al, European Journal of Endocrinology, 1998, vol. 141, pp. 382-386.
Levy et al (Journal of Bioenergetics and Biomembranes, 1998, vol. 30, pp 195-206).
Spitweg et al (Journal of Clinical Endocrinology and Metabolism, 1998, vol. 83, pp. 1746-1751).
Riedel, C., et al., 2001, “Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer,” Trends in Biochemical Sciences, vol. 26, No. 8, pp. 490-496.
Tazebay, UH, et al., 2000, “The mammary gland iodide transporter is expressed during lactation and in breast cancer,” Nauture Medicine, vol. 6, pp. 871-878.
Socolow, EL et al, 1967, “Metabolism of 99m-pertechnetate by the thyroid gland of the rat,” Endocrinology, vol. 80, pp. 337-344.
Dai, G. et al. Rattus norvegicus thyroid sodium/iodide symporter NIS mRNA, complete cds. Database NCBI Accession No. U60282, Jul. 2, 1996.
Dai, G. et al. Na/I symporter, Database NCBI Accession No. 2204393A, Oct. 20, 1996.
Smanik, P.A. et al. “Cloning of the Human Sodium Iodide Symporter,” Biochemical and Biophysical Research Communications 226, 339-345 (1996).
Cancroft and Goldsmith, (99m)Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses. Radiology, 106(2):441-44, Feb. 1973.
Carrasco, N., Iodide transport in the thyroid gland. Biochim. Biophys. Acta., 1154(1):65-82, Jun. 1993.
Caturegli et al., Hypothyroidism in transgenic mice expressing IFN-gamma in the thryoid. Proc. Natl. Acad. Sci. USA, 97(4):1719-24, Feb. 15, 2000.
Dai et al., Cloning and characterization of the thyroid iodide transporter. Nature, 379:458-60, Feb. 1, 1996.
Deleu et al., Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid, 10(2):131-40, Feb. 2000.
Eng et al., Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology, 140(8):3404-10, Aug. 1999.
Eskandari et al., Thyroid Na+/I- symporter: mechanism, stoichiometry, and specificity. J. Biol. Chem., 272(43):27,230-238, Oct. 24, 1997.
Eskin, B.A., Iodine and mammary cancer. Advances in Experimental Medicine and Biology, 91:293-304, 1977.
Eskin et al., Human breast uptake of radioactive iodine. Obstetrics and Gynecology, 44(3):398-402, Sep. 1974.
Filetti et al., Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur. J. Endocrinol., 141(5):443-57, Nov. 1999.
Jhiang et al., An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology, 139(10):4416-19, Oct. 1998.
Kaminsky et al., Na(+)—I(−) symport activity is present in membrane vesicles from thyrotropin-deprived non-I(−)-transport culture thyroid cells. Proc. Natl. Acad. Sci. USA, 91:.789-93, Apr. 1994.
Kaminsky et al., The Na+/I- symporter of the thyroid gland. In Molecular Biology and Function of Carrier Proteins (New York: The Rockefeller University Press, 1993), chap. 20, 251-62.
Kaminsky et al., Inhibition of the Na+/I- symporter by harmaline and 3-amino-1-methyl-5H-pyrido(4,3-b)indole acetate in thyroid cells and membrane vesicles. Eur. J. Biochem., 200(1):203-07, Aug. 1991.
Kilbane et al., Tissue iodine content and serum-mediated (125)I uptake-blocking activity in breast cancer. JCEM, 85(3):1-6, 2000.
Levy et al., N-linked glycosylation of the tyroid Na+/I- symporter (NIS). J. Biol. Chem., 273(35):22,657-663, Aug. 28, 1998.
Levy et al., Identification of a structural requirement for thyroid Na+/I- symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett., 429(1):36-40, Jun. 1998.
Levy et al., The Na+/I- symporter (NIS): recent advances. J. Bioenergy. Biomembr., 30(2):195-206, Apr. 1998.
Levy et al., Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody. Proc. Natl. Acad. Sci. USA, 94:5568-73, May 1997.
Lyttle et al., Peroxidase activity and iodide uptake in hormone-responsive and hormone-independent GR mouse mammary tumors. J. Natl. Cancer Inst., 62(4):1031-34, Apr. 1979.
Ohno et al., The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol.. Cell. Biol., 19(3):2051-60, Mar. 1999.
Saito et al., Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J. Clin. Invest., 101(7)1296-1300, Apr. 1998.
Shimura et al., Iodide uptake and experimental (131)I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+I- symporter gene. Endocrinology, 138(10):4493-96, Oct. 1997.
Smanik et al., Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology, 138(8):3555-58, Aug. 1997.
Spitzweg et al., Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Research, 59:2136-41, May 1, 1999.
Spitzweg et al., Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, ang gastric mucosa. JCEM, 83(5):1746-51, May 1998.
Thorpe, S.M., Increased uptake of iodide by hormone-responsive compared to hormone-independent mammary tumors in GR mice. Int. J. Cancer, 18:345-50, Sep. 1976.
Thorpe and Briand, The ability to concentrate iodide as a marker of hormone dependence in GR mouse mammary tumors. Intl. J. Cancer, 34(1):127-31, Jul. 1984.
Uyttersprot et al., Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid. Mol. Cell. Endocrinol., 131(2):195-203, Aug. 1997.
Vilijn and Carrasco, Expression of the thyroid sodium/iodide symporter in Xenopus laevis oocytes. J. Biol. Chem., 264(20):11,901-903, Jul. 1989.
Carrasco Nancy
Dohan Orsolya
Tazebay Uygar H.
Wapnir Irene L.
Albert Einstein College of Medicine of Yeshiva University
Amster, Rothstein and Ebenstein LLP
Canella Karen A.
University of Medicine and Dentistry of New Jersey
LandOfFree
Methods for the diagnosis and treatment of breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the diagnosis and treatment of breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the diagnosis and treatment of breast cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898315